Sort
39,280 grants matching “leukemia”
CONCEPT SBIR - T-CELL RECEPTORS FOR TREATING PEDIATRIC ACUTE MYELOID LEUKEMIA
$355,000Binbin Chen · Vcreate, Inc. · N43 · FY2024 · CA
Functional and Molecular Dissection of Mutant Calreticulin in Myeloproliferative Neoplasms
$355,000Ann Mullally · Palo Alto Veterans Instit For Research · R01 · FY2024 · HL
Ultrasound-based Diagnosis and Monitoring of Neutropenic Enterocolitis in Children with Acute Lymphoblastic Leukemia
$354,985Viksit Kumar · Novateur Research Solutions, Llc · N43 · FY2024 · CA
THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE THE I-CORP OPTION
$354,964Chuhua Zhong · Gencyte Therapeutics, Inc. · N43 · FY2023 · CA
Studying measurement variability in tumor volume and volume change on MDCT
$354,962Binsheng Zhao · Columbia University Health Sciences · R01 · FY2011 · CA
Reprogramming myeloid cells to inhibit cancer development
$354,961Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2024 · CA
A Mouse Model for Human Gastrointestinal Stromal Tumor
$354,934Peter Besmer · Sloan-Kettering Inst Can Research · R01 · FY2007 · CA
Role of POZ-zinc finger proteins in hemopoietic malignacies
$354,934Pier Paolo Pandolfi · Sloan-Kettering Inst Can Research · R01 · FY2007 · CA
A Mouse Model for Human Gastrointestinal Stromal Tumor
$354,934Peter Besmer · Sloan-Kettering Inst Can Research · R01 · FY2008 · CA
Discovering chemical tools for acute myelogenous leukemia
$354,907Jing-Ruey Joanna Yeh · Massachusetts General Hospital · R01 · FY2011 · CA
Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance
$354,885Thomas Doetschman · University Of Arizona · R01 · FY2008 · AI
Treating CNS malignancies with 131-I-8H9
$354,861Kim Kramer · Sloan-Kettering Inst Can Research · R21 · FY2006 · CA
The role of PKCtheta in T cell and T-ALL migration
$354,850Judy Lin Cannon · University Of New Mexico Health Scis Ctr · R01 · FY2013 · AI
Targeting MLL3 histone methyltransferase
$354,848Yali Dou · University Of Michigan At Ann Arbor · R01 · FY2015 · CA
(PQB6) Genetics of Subclonal Evolution in Pancreatic Cancer
$354,825Christine A Iacobuzio-Donahue · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
LEUKEMOGENESIS BY ABL AND OTHER ONCOGENES
$354,816California Institute Of Technology · R01 · FY2000 · CA
Novel 5HT2C Agonist Drugs with 5HT2A Antagonist Activity for Cocaine Addiction
$354,811Raymond G Booth · University Of Florida · R01 · FY2008 · DA
Hematopoietic Transplantation for AML
$354,797Richard E. Champlin · University Of Tx Md Anderson Can Ctr · P01 · FY2008 · CA
APOBEC3G/CEM15 Inhibition of Lentivirus Replication
$354,743Nathaniel R. Landau · New York University School Of Medicine · R01 · FY2008 · AI
Chaetocin as a Potential Therapy for Multiple Myeloma
$354,669Keith C Bible · Mayo Clinic Rochester · R01 · FY2008 · CA
Cancer Stem Cells in Acute Lymphoblastic Leukemia and Ovarian Carcinoma
$354,656Richard J Jones · Johns Hopkins University · P01 · FY2010 · CA
Cancer and Leukemia Group B: RPCI/SUNYAB
$354,626Roswell Park Cancer Institute Corp · U10 · FY2004 · CA
Transcriptional regulation of TAL1/SCL in normal and malignant hematopoiesis
$354,625Suming Huang · University Of Florida · R01 · FY2011 · HL
IFITM-mediated Inhibition of HIV Infection and Viral Countermeasures
$354,597Shan-Lu Liu · University Of Missouri-Columbia · R01 · FY2014 · AI
MECHANISMS OF TRANSCRIPTIONAL REPRESSION IN DROSOPHILA
$354,580Fred Hutchinson Cancer Research Center · R01 · FY2001 · GM